Healthcare -
Medical - Devices - NASDAQ - US
$ 2.81
-4.1 %
$ 145 M
Market Cap
-2.73
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Sight Sciences, Inc.
| Net Income | -51.5 M |
| Depreciation & Amortization | 712 K |
| Capital Expenditures | -385 K |
| Stock-Based Compensation | 17.1 M |
| Change in Working Capital | 9 M |
| Others | 5.86 M |
| Free Cash Flow | -22.7 M |
Cash Flow
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||
| Net Income | (51.5) | (55.5) | (86.2) | (63.0) | (34.7) | (25.9) | (14.3) |
| Depreciation & Amortization | 0.7 | 0.6 | 0.7 | 0.6 | 0.6 | 0.3 | 63 K |
| Deferred Income Tax | 0 | 0 | 0 | 7.8 | 1.8 | 0.1 | 0 |
| Stock Based Compensation | 17.1 | 14.6 | 13.0 | 5.1 | 0.5 | 0.1 | 52 K |
| Other Operating Activities | 2.4 | 2.3 | 2.3 | 1.3 | (1.1) | 0.7 | 58 K |
| Change in Working Capital | 9.0 | (9.1) | (5.7) | (4.3) | 0.8 | (0.3) | (0.4) |
| Cash From Operations | (22.4) | (47.2) | (76.0) | (52.5) | (32.2) | (25.0) | (14.5) |
| INVESTING CASH FLOW | |||||||
| Capital Expenditures | (0.4) | (0.8) | (1.0) | (0.8) | (1.0) | (0.7) | (0.6) |
| Other Items | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | (0.4) | (0.8) | (1.0) | (0.8) | (1.0) | (0.7) | (0.6) |
| FINANCING CASH FLOW | |||||||
| Common Stock Repurchased | 0 | (0.2) | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 4.2 | 0 | 0 | 0 | 20.5 | 14.0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0.8 | 1.1 | 1.2 | (4.2) | 52.9 | 28.7 | 12.2 |
| Cash From Financing Activities | 5.0 | 1.1 | 1.2 | 252.5 | 73.4 | 42.7 | 12.2 |
| CHANGE IN CASH | |||||||
| Net Change In Cash | (17.8) | (46.9) | (75.7) | 199.2 | 40.3 | 17.0 | (2.8) |
| FREE CASH FLOW | |||||||
| Free Cash Flow | (22.7) | (48.0) | (76.9) | (53.4) | (33.1) | (25.7) | (15.0) |